[go: up one dir, main page]

GB2441445B - Acid containing oxaliplatin formulation - Google Patents

Acid containing oxaliplatin formulation

Info

Publication number
GB2441445B
GB2441445B GB0718274A GB0718274A GB2441445B GB 2441445 B GB2441445 B GB 2441445B GB 0718274 A GB0718274 A GB 0718274A GB 0718274 A GB0718274 A GB 0718274A GB 2441445 B GB2441445 B GB 2441445B
Authority
GB
United Kingdom
Prior art keywords
acid containing
containing oxaliplatin
oxaliplatin formulation
formulation
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB0718274A
Other versions
GB0718274D0 (en
GB2441445A (en
GB2441445A8 (en
Inventor
Darryl Vanstone Whittaker
Aikun Julie Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma Pty Ltd
Original Assignee
Mayne Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904627A external-priority patent/AU2003904627A0/en
Application filed by Mayne Pharma Pty Ltd filed Critical Mayne Pharma Pty Ltd
Priority to GB0718274A priority Critical patent/GB2441445B/en
Priority claimed from GB0606187A external-priority patent/GB2421911A/en
Publication of GB0718274D0 publication Critical patent/GB0718274D0/en
Publication of GB2441445A publication Critical patent/GB2441445A/en
Publication of GB2441445A8 publication Critical patent/GB2441445A8/en
Application granted granted Critical
Publication of GB2441445B publication Critical patent/GB2441445B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0718274A 2003-08-28 2004-08-27 Acid containing oxaliplatin formulation Expired - Lifetime GB2441445B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0718274A GB2441445B (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003904627A AU2003904627A0 (en) 2003-08-28 Pharmaceutical Formulation
GB0606187A GB2421911A (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulations
GB0718274A GB2441445B (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulation

Publications (4)

Publication Number Publication Date
GB0718274D0 GB0718274D0 (en) 2007-10-31
GB2441445A GB2441445A (en) 2008-03-05
GB2441445A8 GB2441445A8 (en) 2008-03-17
GB2441445B true GB2441445B (en) 2008-04-23

Family

ID=38670158

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0718274A Expired - Lifetime GB2441445B (en) 2003-08-28 2004-08-27 Acid containing oxaliplatin formulation

Country Status (1)

Country Link
GB (1) GB2441445B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0806728A2 (en) * 2007-01-22 2011-09-13 Pliva Lachema As pharmaceutical composition and method of producing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043355A2 (en) * 1998-02-25 1999-09-02 Sanofi-Synthelabo Formulations containing oxaliplatin
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
EP1466600A1 (en) * 2003-03-28 2004-10-13 Stada Arzneimittel Ag Ready-to-use oxaliplatin solutions
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043355A2 (en) * 1998-02-25 1999-09-02 Sanofi-Synthelabo Formulations containing oxaliplatin
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US20030109515A1 (en) * 2001-12-06 2003-06-12 Pharmacia Italia, Spa. Pharmaceutical formulation of a platinum derivative
EP1466600A1 (en) * 2003-03-28 2004-10-13 Stada Arzneimittel Ag Ready-to-use oxaliplatin solutions
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions

Also Published As

Publication number Publication date
GB0718274D0 (en) 2007-10-31
GB2441445A (en) 2008-03-05
GB2441445A8 (en) 2008-03-17

Similar Documents

Publication Publication Date Title
IL166623A0 (en) Aripiprazole complex formulation
AU2003296419A1 (en) Pyrenyloxysulfonic acid fluorescent agents
PL1660431T3 (en) Phenoxyacetic acid derivatives
EP1684689A4 (en) Extended release venlafaxine formulation
IL174392A0 (en) Stable lansoprazole formulation
IL158493A0 (en) Pharmaceutical compositions containing venlafaxine
IL173726A (en) Pharmaceutical compositions comprising n-n-dihaloamino acid and uses thereof
IL173290A0 (en) Liquid formulation
TWI341200B (en) Telmisartan acid addition salt
IL171942A0 (en) Compositions containing ecteinascidin-743
EP1603547A4 (en) Trospium containing compositions
AU2003226487A8 (en) Formulation
GB0316206D0 (en) Pharmaceutical formulation
EP1584320A4 (en) Cosmetic preparation containing glycerylamino acid derivative
GB0606187D0 (en) Acid containing oxaliplatin formulations
DE60327253D1 (en) FOOD COMPOSITION CONTAINING L (+) - MILKY ACID
GB0312195D0 (en) Formulation
PL378119A1 (en) Carboxylic acid compounds
IL158172A0 (en) Pharmaceutical compositions containing (-)-hydroxycitric acid
ZA200409494B (en) Cosmetic compositions containing salts of malonic acid.
GB0328527D0 (en) Antimicrobial gelling formulation
AU2003291642A8 (en) Pyrazoloazepine compounds as pharmaceutical agents
GB2441445B (en) Acid containing oxaliplatin formulation
IL174589A0 (en) Pharmaceutical compositions containing tetrahydrobiopterin
IL172211A0 (en) Anti-corrosive additive containing a dioic acid compound, processes for the preparation thereof and for using the same

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1111894

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1111894

Country of ref document: HK

PE20 Patent expired after termination of 20 years

Expiry date: 20240826